DR DE Ceuninck SRL
DR DE Ceuninck reported total assets of 354,829 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Jul 2026).
The score of DR DE Ceuninck shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -33 % Total assets -25 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR DE Ceuninck's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 82,263 € | ||||
| Equity | 183,481 € | ||||
| Cash | 195,129 € | ||||
| EBITDA | 138,575 € | ||||
| Total assets | 354,829 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 30 Sep 2021filed on 14 Feb 2022
DR DE Ceuninck's financial analysis
- Solvency51.7%sector median: 72.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR DE Ceuninck
DR DE Ceuninck's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0663.696.170
- VAT number
- BE0663696170
- Peppol
- Registered · 0208:0663696170 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Sep 2016
- Registered office
- 2018 Antwerp
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- General medical practice activities (NACE 86210)
DR DE Ceuninck (SRL) has been based in Antwerp since 2016, active in: general medical practice activities. For 2025, it reports a net profit of 82,263 € and equity of 183,481 €; its revenue is not published. Its solvency stands at 51.7%, below the median of its sector (72.4%).
Companies similar to DR DE Ceuninck
Companies in the same business, of comparable size and area, outside its group.
- DR. JAN DE WIT - Huisarts General medical practice activities Kapellen · balance sheet 357,734 €
- Dr. Joulia Tepaeva General medical practice activities Antwerp · balance sheet 351,880 €
- Dokter E. Raats General medical practice activities Mortsel · balance sheet 351,837 €
- Chiropractor Dean Corthier General medical practice activities Antwerp · balance sheet 358,231 €
- Heyde Marc General medical practice activities Florenville · balance sheet 354,801 €
- Medisol General medical practice activities Waterloo · balance sheet 355,151 €
- Cabinet Médical MEURENS-GROSCH General medical practice activities Olne · balance sheet 351,741 €
- Endocrine Consult General medical practice activities Villers-la-Ville · balance sheet 350,027 €
Frequently asked questions about DR DE Ceuninck
What is the revenue of DR DE Ceuninck?
DR DE Ceuninck files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR DE Ceuninck?
In Belgium, the VAT number is the company number prefixed with BE: BE0663696170 for DR DE Ceuninck, if the company is VAT-registered. Its company number (CBE) is 0663.696.170.
Where is the registered office of DR DE Ceuninck?
According to the CBE register, the registered office of DR DE Ceuninck is in 2018 Antwerp.
What is the equity of DR DE Ceuninck?
At the close of the 2025 financial year, the equity of DR DE Ceuninck amounts to 183,481 €, a solvency of 51.7% of total assets.
Who manages DR DE Ceuninck?
The register lists 1 active mandates at DR DE Ceuninck. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DR DE Ceuninck
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →